Press "Enter" to skip to content

Applied UV, Inc., Reports 2020 Financial Results & Continued Acquisition Strategy

Applied UV, Inc., delivered its annual report to the U.S. Securities and Exchange Commission this week, reporting $5.7 million in net sales and a $3.4 million net loss for the year ending Dec. 31, 2020, and assets exceeding liabilities by $9.7 million at Dec. 31, 2020. The filing on Form 10-K is available at https://www.sec.gov/Archives/edgar/data/0001811109/000160706221000068/auvi123120form10k.htm at no charge. AUVI is focused on the development and acquisition of technology that address infection control in the healthcare, hospitality, commercial and municipal markets. The Company has two wholly owned subsidiaries – SteriLumen, Inc., and Munn Works, LLC. SteriLumen’s connected platform for Data…
This content is viewable by members only. Visit MY ACCOUNT on the top menu to log in or to register for a 30 day free trial or purchase a subscription for UV Reporter 1 Year Single Membership or UV Reporter 1 Year Group Membership - $189 for first member and $25 for each additional member.